Skip to Content

Lurasidone

In the US, Lurasidone (lurasidone systemic) is a member of the drug class atypical antipsychotics and is used to treat Bipolar Disorder, Borderline Personality Disorder, Schizoaffective Disorder and Schizophrenia.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

N05AE05

CAS registry number (Chemical Abstracts Service)

0367514-87-2

Chemical Formula

C28-H36-N4-O2-S

Molecular Weight

492

Therapeutic Category

Neuroleptic agent

Chemical Name

(3aR,4S,7R,7aS)-{(1R,2R)-2-[4-(1,2-benzisotiazol-3-yl)piperazin-1-ylmetyl]cyclohexylmetyl}hexahydro-4,7-metano-2H-isoindole-1,3-dione (WHO)

Foreign Names

  • Lurasidonum (Latin)
  • Lurasidon (German)
  • Lurasidone (French)
  • Lurasidona (Spanish)

Generic Names

Brand Names

  • Latuda
    Takeda, Poland; Takeda Pharma, Slovenia; Medius, Switzerland; Sunovion, United States; Sunovion Pharmaceuticals, Canada; Sunovion Pharmaceuticals Europe, United Kingdom; Takeda, Germany; Takeda, Finland

International Drug Name Search

Glossary

TermDefinition
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide